湖南景峰医药股份有限公司2025年第二次临时股东大会决议公告

Meeting Overview - The second extraordinary general meeting of shareholders was held on November 19, 2025, with both on-site and online voting options available [3][4] - A total of 1,052 shareholders attended, representing 210,541,180 shares, which accounts for 23.9313% of the total voting shares [4] Voting Results - The proposal to reappoint the accounting firm received 99.2387% approval from the attending shareholders, with 208,938,280 shares in favor [8] - The proposal to elect a non-independent director was approved with 99.4873% support, totaling 209,461,780 shares [11] Legal Compliance - The meeting was witnessed by lawyers from Guangdong Chongli Law Firm, confirming that the procedures and resolutions complied with relevant laws and regulations [13]